ASCO Guidelines

180 Episodes

1. PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation Update

   Published: 10/3/2022
2. Secondary Prevention of Cervical Cancer Resource-Stratified Guideline Update

   Published: 9/26/2022
3. Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update

   Published: 9/21/2022
4. Integrative Medicine for Pain Management in Oncology: SIO-ASCO Guideline

   Published: 9/19/2022
5. Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update

   Published: 8/4/2022
6. Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO Living Guideline (Part 1)

   Published: 7/11/2022
7. Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO Living Guideline (Part 2)

   Published: 7/11/2022
8. Biomarkers for Systemic Therapy in Metastatic Breast Cancer Guideline Update

   Published: 6/27/2022
9. Management of Metastatic Clear Cell Renal Cell Carcinoma Guideline

   Published: 6/21/2022
10. Systemic Therapy for Melanoma Rapid Recommendation Update

    Published: 6/3/2022
11. Management of Advanced HER2-Positive Breast Cancer and Brain Metastases Guideline Update

    Published: 5/31/2022
12. Systemic Therapy for Advanced HER2-Positive Breast Cancer Guideline Update

    Published: 5/31/2022
13. Exercise, Diet, and Weight Management During Cancer Treatment Guideline

    Published: 5/16/2022
14. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline

    Published: 5/13/2022
15. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update

    Published: 4/19/2022
16. Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer Rapid Recommendation Update

    Published: 4/13/2022
17. Management and Care of Patients with Invasive Cervical Cancer: Resource-Stratified Guideline Rapid Recommendation Update

    Published: 3/7/2022
18. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

    Published: 2/24/2022
19. Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer Provisional Clinical Opinion

    Published: 2/17/2022
20. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected NSCLC Guideline Rapid Recommendation Update

    Published: 2/14/2022